The findings raise questions about whether the administration’s “most favored nation” deals are having a meaningful impact on patients.
Donald Trump has repeatedly said his deals with drugmakers would bring down prescription drug prices in the U.S. But a report released by Senate Democrats finds prices have continued to climb — in some cases, sharply.
The report — released Thursday by Sen. Bernie Sanders, I-Vt., the ranking member on the Senate Health, Education, Labor and Pensions Committee, ahead of a hearing focused on drug prices — found that companies that signed drug pricing deals with Trump have raised the cost of hundreds of medications and launched new ones at an average price of $353,000 a year.
“American people continue to pay by far the highest prices in the world for prescription drugs, and that was true before President Trump was president. In most cases, it is even more accurate today," Sanders said at the hearing.